Enanta Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ENTA
Share price (9/4/26): $14.08
Market cap (9/4/26): $410 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q3

ended 03/31/26 Q2

ended 12/31/25 Q1

ended 09/30/25 FY 2025

ended 06/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Deep Track Capital, LP

Farallon Capital Management, L.L.C.

Rottinghaus Scott T.

Vanguard Group Inc

News Filter

Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2026

Material Definitive Agreement, Financial Statements or Exhibits

Announces Advancement of Its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus

Reports Financial Results for Its Fiscal Second Quarter Ended March 31, 2026

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission